| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 17.535 | 22.161 | 23.205 | 16.237 | 15.639 | 9.298 | 12.529 | 13.452 | 17.572 | 19.779 |
| Total Income - EUR | 17.535 | 22.161 | 23.205 | 16.237 | 15.639 | 9.901 | 12.529 | 13.452 | 17.572 | 20.016 |
| Total Expenses - EUR | 16.695 | 19.986 | 19.654 | 19.060 | 19.136 | 11.153 | 11.914 | 13.373 | 16.854 | 19.522 |
| Gross Profit/Loss - EUR | 841 | 2.175 | 3.552 | -2.823 | -3.496 | -1.252 | 615 | 79 | 718 | 494 |
| Net Profit/Loss - EUR | 315 | 1.953 | 3.320 | -2.985 | -3.653 | -1.341 | 490 | -55 | 542 | 333 |
| Employees | 3 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Laborator Dentar Mandomax S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.048 | 3.196 | 2.344 | 1.518 | 880 | 532 | 196 | 14 | 0 | 0 |
| Current Assets | 923 | 3.735 | 7.732 | 5.438 | 2.379 | 1.100 | 1.904 | 2.192 | 2.796 | 3.261 |
| Inventories | 0 | 0 | 0 | 0 | 39 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 14 | 35 | 48 | 40 | 0 | 37 | 173 | 811 | 20 | 0 |
| Cash | 908 | 3.700 | 7.684 | 5.398 | 2.340 | 1.062 | 1.731 | 1.381 | 2.775 | 3.261 |
| Shareholders Funds | 4.070 | 5.982 | 9.201 | 6.046 | 2.277 | 892 | 1.362 | 1.311 | 1.850 | 2.172 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 901 | 948 | 876 | 909 | 982 | 739 | 738 | 906 | 958 | 1.101 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3250 - 3250" | |||||||||
| CAEN Financial Year |
3250
|
|||||||||
Comments - Laborator Dentar Mandomax S.r.l.